Srs Capital Advisors, Inc. Ptc Therapeutics, Inc. Transaction History
Srs Capital Advisors, Inc.
- $977 Million
- Q2 2024
A detailed history of Srs Capital Advisors, Inc. transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Srs Capital Advisors, Inc. holds 104 shares of PTCT stock, worth $3,749. This represents 0.0% of its overall portfolio holdings.
Number of Shares
104Holding current value
$3,749% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding PTCT
# of Institutions
215Shares Held
79.2MCall Options Held
122KPut Options Held
212K-
Vanguard Group Inc Valley Forge, PA8.97MShares$324 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA8.21MShares$296 Million0.05% of portfolio
-
Black Rock Inc. New York, NY7.77MShares$280 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.39MShares$267 Million3.78% of portfolio
-
Armistice Capital, LLC New York, NY6.96MShares$251 Million2.77% of portfolio
About PTC THERAPEUTICS, INC.
- Ticker PTCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,541,000
- Market Cap $2.58B
- Description
- PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...